PL BioScience Expands Headquarters to Boost HPL Production

PL BioScience GmbH has announced a significant expansion of its headquarters in Aachen, Germany, to meet the growing demand for Human Platelet Lysate (HPL). The new facility spans over 1,200 m², bolstering the company’s production capabilities to 20,000L annually. This positions PL BioScience as the leading global provider of HPL products, enhancing its capability to deliver animal-free culture supplements.

The expansion includes dedicated space for production, storage, and offices. It marks PL BioScience as the first in the industry with a dual-source GMP-grade strategy, securing a reliable HPL supply. This development also aids in job creation in the region and supports research and innovation in the field.

CEO Dr. Hatim Hemeda underscores the expansion as a pivotal step in aligning with the global increase in HPL demand. The move is set for September 2025, integrating operations to fuel continued growth and product innovation, including the company’s artificial HPL advancements.